Dr. Duncan specializes in gastrointestinal surgical oncology, including surgery of the esophagus, stomach, intestine, colon and rectum, gallbladder and pancreas, adrenal and retroperitoneal sarcoma. He has national and international expertise in gastric cancer and hereditary gastric cancer including CDH-1. He wrote the Johns Hopkins Patient Guide for Cancer of the Stomach and Esophagus. Dr. Duncan gives lectures and presentations nationally and internationally on Gastric and GI cancer surgery and works with Johns Hopkins International on cancer programs and centers overseas. Dr. Duncan is rated as a Distinguished provider by MediFind in the treatment of Stomach Cancer. His top areas of expertise are Stomach Cancer, Familial Colorectal Cancer, Gastrointestinal Stromal Tumor, Gastrectomy, and Hernia Surgery.

Dr. Katherine Bever is a medical oncologist in Baltimore, caring for patients with gastrointestinal malignancies, including gastric, pancreatic, colorectal, neuroendocrine and biliary cancers. Dr. Bever received her undergraduate degree in biophysics from Johns Hopkins University. She earned her M.D. from the University of Maryland School of Medicine. She completed her residency in internal medicine at Boston University School of Medicine and performed a fellowship in medical oncology at Johns Hopkins. Dr. Bever joined the Johns Hopkins faculty in 2015. Prior to joining Johns Hopkins, Dr. Bever was an internist at the Amyloidosis Center at Boston University School of Medicine. Dr. Bever was recognized with a Pearl M. Stetler Fellowship Award in 2018. She is a member of several professional organizations, including the Society for Immunotherapy of Cancer, the American Association of Clinical Research and the American Society of Clinical Oncology. Dr. Bever is rated as a Distinguished provider by MediFind in the treatment of Stomach Cancer. Her top areas of expertise are Stomach Cancer, Pancreatic Cancer, Familial Pancreatic Cancer, Appendix Cancer, and Pancreaticoduodenectomy.

Gastroenterologist Saowanee Ngamruengphong specializes in the endoscopic diagnosis and management of gastrointestinal malignancies, premalignant and malignant lesions in the gastrointestinal tract (e.g., early gastric cancer, Barrett's esophagus-associated neoplasia), esophageal cancer, colon polyps or early colorectal cancer, and pancreatic and biliary disease. Dr. Ngamruengphong earned a medical degree from Chulalongkorn University and completed residency training at the Texas Tech University Health Sciences Center. She undertook fellowship training in gastroenterology at the Mayo School of Graduate Medical Education and further fellowship training in therapeutic endoscopy at The Johns Hopkins Hospital. Her research interests include endoscopic resection and the management of precancerous or cancerous gastrointestinal lesions. Dr. Ngamruengphong is a member of several professional organizations, including the Thai Medical Council, the American College of Gastroenterology and the American Gastroenterological Association. Videos Endoscopic Submucosal Dissection (ESD) — Eileen’s Story Recent News Articles and Media Coverage A Rare, Stomach-Saving Endoscopic Procedure, Inside Tract (Spring 2021) Case Presentation: ESD-TAMIS, Inside Tract (Spring 2019) Innovative Approaches to Colorectal Surgery Benefit Patients, Surgery (Winter 2019) For Colorectal Polyps: Early Detection and Minimally Invasive Endoscopic Resection, Inside Tract (Winter, 2019) The Cutting Edge of Endoscopic Resection, Inside Tract (Spring, 2017) Stomach Cancer: Know Your Risks & Treatment Options, Johns Hopkins Surgery (4/26/2017). Dr. Ngamruengphong is rated as an Advanced provider by MediFind in the treatment of Stomach Cancer. Her top areas of expertise are Achalasia, Pancreatic Pseudocyst, Stomach Cancer, Endoscopy, and Gastric Bypass.

Dr. Stephen J. Meltzer is a Professor of Medicine and Oncology at Johns Hopkins University, Division of Gastroenterology. He is the Director of GI Early Detection Biomarkers Laboratory and a member of the Johns Hopkins Kimmel Cancer Center. His research interests are Gastrointestinal cancer and precancer biomarker discover, development and validation; genomics, epigenomics and bioinformatics, early detection of cancer, outcomes research in cancer and precancer, risk stratification prediction in cancer and precancer, Barrett's esophagus, inflammatory bowel disease-associated cancer, liver cancer and gastric cancer. After receiving degree in Medicine at the State University of New York Medical School, Dr. Meltzer interned at Tulane University in New Orleans and University of Texas Medical Branch in Galveston, TX. He completed his fellowship training program in the University of Colorado and the Lenox Hill Hospital. He was an Assistant Professor in UCLA, Center for Health Science in 1987. Prior to joining the faculty at Johns Hopkins in 2006, he was Professor of Medicine and Pharmacology, Founder and Head of Aero digestive Cancer/Biomarker Program in School of Medicine, University of Maryland at Baltimore. He is an Associate Editor of Cancer Research and a member of the editorial board of Esophageal. He has published 152 original scientific papers in high-impact scientific journals. He also has 43 chapters, review articles, editorials, or letters to the editor; 1 book; and 139 abstracts to his name. He has given a plethora of invited lectures around the world, all involving his principal field of esophageal and gastrointestinal cancer research. He has been the recipient of numerous prestigious national and international awards, including the Robert and Sally D. Funderburg Award in Gastric Cancer Biology and membership in the American Society for Clinical Investigation. Special Interests: Gastrointestinal cancer and precancer biomarker discover, development and validation; genomics, epigenomics and bioinformatics, early detection of cancer, outcomes research in cancer and precancer, risk stratification prediction in cancer and precancer. Barrett's esophagus, inflammatory bowel disease-associated cancer, liver cancer, gastric cancer. Dr. Meltzer is rated as an Advanced provider by MediFind in the treatment of Stomach Cancer. His top areas of expertise are Barrett Esophagus, Esophageal Cancer, Stomach Cancer, Colorectal Cancer, and Endoscopy.

Ilene S. Browner, M.D. specializes in geriatric oncology. Dr. Browner is rated as an Advanced provider by MediFind in the treatment of Stomach Cancer. Her top areas of expertise are Colorectal Cancer, Familial Colorectal Cancer, Pancreatic Cancer, Familial Pancreatic Cancer, and Endoscopy.

William Burns, M.D., is an assistant professor of surgery at the Johns Hopkins University School of Medicine and a surgeon within the Division of Hepato-Pancreato-Biliary & Gastrointestinal Surgical Oncology at The Johns Hopkins Hospital. Prior to joining the faculty at Johns Hopkins, Dr. Burns served as an assistant professor of surgery at the University of Michigan, as well as an attending physician at the University of Michigan Health Systems and the VA Ann Arbor Healthcare System. Dr. Burns received his medical degree from Yale University School of Medicine and was awarded a research training fellowship by the Howard Hughes Medical Institute. He completed an internship and residency in general surgery at The Johns Hopkins Hospital followed by clinical fellowship training in complex general surgical oncology at The University of Texas MD Anderson Cancer Center. Additionally, he completed postgraduate research fellowships in the field of cancer immunotherapy and tumor immunology at the National Cancer Institute and the MD Anderson Cancer Center. Dr. Burns specializes in treating patients with tumors of the pancreas and gastrointestinal tract, sarcoma and melanoma. He is trained in traditional and minimally invasive surgical techniques. Furthermore, he works closely with colleagues in medical and radiation oncology to provide comprehensive cancer care. His research focuses on immune cell-tumor cell interactions to improve outcomes in patients with pancreatic cancer, cancer immunotherapy for solid tumors, the role of lymph node surgery in the treatment of cancer, and human biospecimen analysis to guide therapy in patients with cancer. He is a member of several professional societies, including the American College of Surgeons, Society of Surgical Oncology, Association of Academic Surgery, and Society of Immunotherapy for Cancer. Dr. Burns is rated as an Advanced provider by MediFind in the treatment of Stomach Cancer. His top areas of expertise are Neuroendocrine Tumor, Familial Pancreatic Cancer, Familial Colorectal Cancer, Small Bowel Resection, and Pancreatectomy.

Marcia (Mimi) Canto, M.D., M.H.S. is a Professor of Medicine at The Johns Hopkins University School of Medicine. She is also the Director of Endoscopy at the Johns Hopkins Hospital. Dr. Canto received her Bachelor of Science degree from the University of the Philippines in Manila in 1981 (summa cum laude). She received her Doctor of Medicine degree in 1985 from the University of the Philippines and completed her training in Internal Medicine from State University of New York Sciences Center in Brooklyn, Brooklyn, New York. Dr. Canto completed a postdoctoral fellowship in Gastroenterology-Hepatology at The Johns Hopkins University School of Medicine and received a Master of Health Science in Clinical Epidemiology from The Johns Hopkins University School of Hygiene and Public Health in 1993. Dr. Canto came back to Johns Hopkins after spending three years at Case Western Reserve University in Cleveland, Ohio for advanced endoscopic training. Her primary clinical interests include endoscopy, particularly the use of endoscopic ultrasound (EUS) in detecting early pancreatic cancer and its precursors. She has recently shown that endoscopic ultrasound can be used to detect asymptomatic precancerous lesions in patients with a family history of pancreatic cancer. Dr. Canto is rated as an Advanced provider by MediFind in the treatment of Stomach Cancer. Her top areas of expertise are Barrett Esophagus, Familial Pancreatic Cancer, Gastroesophageal Reflux Disease (GERD), Endoscopy, and Gastrectomy.

Gastroenterologist Mouen Khashab specializes in therapeutic endoscopy, and he oversees this group of practitioners across the Johns Hopkins enterprise. Nationally and internationally known in the field of interventional endoscopy, Dr. Khashab has contributed immensely to the field’s advancement as a minimally invasive means to treat gastrointestinal and pancreaticobiliary disorders. Dr. Khashab earned his medical degree from the American University of Beirut Faculty of Medicine, and subsequently completed a residency in internal medicine and a fellowship in gastroenterology at Indiana University. He then completed a two-year fellowship at The Johns Hopkins Hospital before joining the faculty in 2011. A busy researcher, Dr. Khashab has published more than 600 papers in peer-reviewed journals. In 2013, he described the procedure called gastric peroral endoscopic myotomy (known as G-POEM) and was able to disseminate and teach it all over the world. Other procedures that he expanded include peroral endoscopic myotomy (POEM), peroral endoscopic myotomy with fundoplication (POEM-F), Zenker’s peroral endoscopic myotomy (Z-POEM) and full thickness resection. In 2022, he received the Master Endoscopist Award from the American Society for Gastrointestinal Endoscopy (ASGE) for his numerous contributions to the field. His procedural expertise includes endoscopic retrograde cholangiopancreatography (ERCP), endoscopic ultrasound (EUS), interventional EUS, submucosal endoscopy, POEM/achalasia, endoscopic mucosal resection, endoscopic submucosal dissection, luminal stenting, large polyp resection and Barrett’s therapy, among others. Dr. Khashab is involved with multiple gastrointestinal societies and has served on many committees, including the ASGE Standards of Practice Committee, which is in charge of formulating guidelines for the practice of endoscopy. He has also served as an associate editor for the journal Endoscopy, a premier journal in the field. Khashab is a highly sought-after speaker at national and international conferences, and he has participated in multiple live endoscopy conferences. Outside of academic medicine, Dr. Khashab is an entrepreneur. His major interest is in new technology and medical devices, and his goal is to disrupt the field by introducing technology that makes endoscopic procedures safer, easier, efficient and more scalable. Dr. Khashab is rated as an Advanced provider by MediFind in the treatment of Stomach Cancer. His top areas of expertise are Achalasia, Pancreatic Pseudocyst, Bile Duct Obstruction, Endoscopy, and Gastric Bypass.

Learn more at marylandoncology.com. Dr. Sastry is rated as an Advanced provider by MediFind in the treatment of Stomach Cancer. Her top areas of expertise are Paget Disease of the Breast, Breast Cancer, Iron Deficiency Anemia, and Childhood Iron Deficiency Anemia.

Debashish Bose is a Surgical Oncologist and a General Surgeon in Baltimore, Maryland. Dr. Bose is rated as an Experienced provider by MediFind in the treatment of Stomach Cancer. His top areas of expertise are Pancreatic Pseudocyst, Pancreatic Cancer, Familial Pancreatic Cancer, Pancreatectomy, and Small Bowel Resection. Dr. Bose is currently accepting new patients.

Md Siddiqui is a Hematologist Oncology specialist and a Hematologist in Salisbury, Maryland. Dr. Siddiqui is rated as an Experienced provider by MediFind in the treatment of Stomach Cancer. His top areas of expertise are Pulmonary Embolism, Inflammatory Breast Cancer, Angiosarcoma, and Childhood Iron Deficiency Anemia. Dr. Siddiqui is currently accepting new patients.

Charles Rabkin is a primary care provider, practicing in Internal Medicine in Rockville, Maryland. Dr. Rabkin is rated as a Distinguished provider by MediFind in the treatment of Stomach Cancer. His top areas of expertise are Stomach Cancer, Helicobacter Pylori Infection, Gastritis, Pernicious Anemia, and Hormone Replacement Therapy (HRT).

Mark Steves is a Surgical Oncologist and a General Surgeon in Silver Spring, Maryland. Dr. Steves is rated as a Distinguished provider by MediFind in the treatment of Stomach Cancer. His top areas of expertise are Pseudomyxoma Peritonei, Familial Colorectal Cancer, Pancreatic Cancer, Pancreatectomy, and Gastrectomy. Dr. Steves is currently accepting new patients.

Yixing Jiang is a Hematologist Oncology specialist and a Hematologist in Baltimore, Maryland. Dr. Jiang is rated as a Distinguished provider by MediFind in the treatment of Stomach Cancer. Her top areas of expertise are Colorectal Cancer, Familial Colorectal Cancer, Familial Pancreatic Cancer, Anal Cancer, and Gastrostomy. Dr. Jiang is currently accepting new patients.

Joseph Bennett is a General Surgeon and a Surgical Oncologist in Randallstown, Maryland. Dr. Bennett is rated as a Distinguished provider by MediFind in the treatment of Stomach Cancer. His top areas of expertise are Pancreatic Adenoma, Pancreatic Cancer, Familial Pancreatic Cancer, Pancreatectomy, and Small Bowel Resection. Dr. Bennett is currently accepting new patients.

Kasra Adham is a Gastroenterologist in Temple Hills, Maryland. Dr. Adham is rated as an Advanced provider by MediFind in the treatment of Stomach Cancer. His top areas of expertise are Gastrointestinal Bleeding, Chronic Idiopathic Constipation (CIC), Familial Pancreatic Cancer, Endoscopy, and Gastrectomy.

Dr. Shin specializes Barrett's esophagus, pancreatobiliary disease (pancreatic cyst, family history of pancreatic cancer), GI malignancy, and advanced endoscopy, including endoscopic retrograde cholangiopancreatography (ERCP) and endoscopic ultrasound (EUS). Dr. Shin is rated as an Experienced provider by MediFind in the treatment of Stomach Cancer. Her top areas of expertise are Pancreatic Cancer, Familial Pancreatic Cancer, Bile Duct Stricture, Endoscopy, and Pancreaticoduodenectomy.

Dr. Ross C. Donehower is an oncologist in the Baltimore area, caring for patients with gastrointestinal cancers. He was part of the team that developed premedications that allowed paclitaxel — a chemotherapy medication now used to treat several types of cancers — to be safely given to patients. The Virginia and D.K. Ludwig Professor in Clinical Investigation of Cancer, he serves as the director of the Hematology & Medical Oncology Fellowship Program and director of the Division of Medical Oncology at the Johns Hopkins School of Medicine. Dr. Donehower received his undergraduate degree from Hamline University and earned his M.D. from the University of Minnesota. He completed his residency at The Johns Hopkins Hospital. Dr. Donehower joined the Johns Hopkins faculty in 1980. Prior to joining Johns Hopkins, Dr. Donehower was a surgeon with the U.S. Public Health Service and a clinical associate of the medicine branch and clinical pharmacology branch at the National Cancer Institute. His research interests include gastrointestinal cancers, new anticancer drug development and pharmacology. Dr. Donehower serves on the editorial boards of numerous scholarly journals, including the International Journal of Oncology. He has been recognized by the American Society of Clinical Oncology with a 2017 Excellence in Teaching Award. He is a member of several professional organizations, including the American College of Physicians, the American Society of Clinical Oncology and the American Association for Cancer Research. Dr. Donehower is rated as an Experienced provider by MediFind in the treatment of Stomach Cancer. His top areas of expertise are Colorectal Cancer, Neuroendocrine Tumor, Familial Colorectal Cancer, Pancreaticoduodenectomy, and Hepato-Pancreato-Biliary Surgery.

Jin He, M.D., Ph.D., is a professor of surgery at the Johns Hopkins University School of Medicine and is the Division Chief of Hepato-Pancreato-Biliary & Gastrointestinal Surgical Oncology. Dr. He specializes in diseases and tumors of the pancreas, liver, bile duct, and gallbladder. He performs open as well as minimally invasive (robotic and laparoscopic) surgery, including the Whipple procedure. Dr. He received his medical degree from Beijing Medical University and a Ph.D. in oncology from Fudan University Shanghai Medical College. He completed the Halsted general surgery residency training at Johns Hopkins, followed by an ACGME accredited fellowship in complex general surgical oncology at Johns Hopkins. Dr. He is the John Cameron Professor of Alimentary Tract Diseases. Dr. He’s research focuses on personalized treatment through stratifying pancreatic tumors on their genetic features. He holds several patents in anti-cancer vascular targeting agents and has published extensively in peer-reviewed journals and lectured internationally. He serves on several national committees, including the NCCN panel on neuroendocrine tumors and the Alliance for Clinical Trials in Oncology. Dr. He is rated as an Experienced provider by MediFind in the treatment of Stomach Cancer. His top areas of expertise are Pancreatic Cancer, Neuroendocrine Tumor, Cholangiocarcinoma (Bile Duct Cancer), Pancreaticoduodenectomy, and Pancreatectomy.

Josephine (Joy) Feliciano, M.D., is an assistant professor of oncology at The Johns Hopkins University School of Medicine and a faculty member of the Johns Hopkins Kimmel Cancer Center. She serves as medical director of the Thoracic Oncology Program at Johns Hopkins Bayview Medical Center, as well as co-director of the outpatient oncology clinic at Johns Hopkins Bayview. Dr. Feliciano completed both undergraduate and postgraduate medical training at Georgetown University, as well as residency training, where she was selected as chief resident. She spent three years at Northwestern completing clinical training in hematology and oncology, then joined the faculty at University of Maryland Greenberg Cancer Center. At the University of Maryland, Feliciano focused on lung cancer screening and health disparities research for patients with lung cancer. While there, she also earned a certificate degree in the Epidemiology and Human Genetics Program for Clinical Investigation. Dr. Feliciano is also a member of the Miller Coulson Academy of Clinical Excellence. She also serves as the inaugural Medical Director of the Sidney Kimmel Cancer Diagnostic and Treatment Planning Center. Dr. Feliciano is rated as an Experienced provider by MediFind in the treatment of Stomach Cancer. Her top areas of expertise are Non-Small Cell Lung Cancer (NSCLC), Lung Cancer, Small Cell Lung Cancer (SCLC), and Gastroesophageal Junction Cancer.